David Smoller
InvestorGeneral Partner at Cultivation Capital Β· Board director at Panome Bio Β· Board director at Solis Agrosciences Β· Board director at Canopy Biosciences
St. Louis, Missouri
Writes $100K β $3.5M checks Β· typically $1.8M
About
David Smoller is a life sciences executive who was CEO of Sage Labs, a gene-editing-based contract research organization acquired by Horizon Discovery, where he then served as Chief Business Officer and board member until December 2015. He previously held roles at Sigma-Aldrich Corporation, including Chief Scientific Officer and President of its Research Biotech Business Unit, and founded ProteoPlex (acquired by Merck KGaA) and Genome Systems Inc. (acquired by Incyte Corporation, where he later became Senior Vice President). He holds a doctorate in Molecular Biology and a bachelor's degree in Biology from Emory University.
ContactΒ· self-published, not guessed
Invests in
Biotech
Board director at Panome Bio
Intro paths
In turn, David can intro founders to Panome Bio's investors below.
Panome Bio's investors Β· 3
Co-founders at Panome Bio
Board director at Solis Agrosciences
Intro paths
In turn, David can intro founders to Solis Agrosciences's investors below.
Solis Agrosciences's investors Β· 2
Board director at Canopy Biosciences
Intro paths
In turn, David can intro founders to Canopy Biosciences's investors below.
Canopy Biosciences's investors Β· 2
Experience
- Washington University in St. Louis Office of Technology Management (Tech Transfer)Entrepreneur in Residencecurrent2025 β present
- BioGenerator VenturesEntrepreneur in Residencecurrent2018 β presentSt Louis, Missouri, United States
- Panome BioCo-Founder/Board Membercurrent2022 β present
- Solis AgrosciencesCo-Founder/Board Membercurrent2022 β present
- Vector Laboratories, Inc.Board Membercurrent2021 β present
- Cultivation CapitalGeneral Partnercurrent2012 β presentGreater St. Louis
- ProteoWiseBoard Member2010 β 2026
- Big Bend Auto Center IncCompany Owner2016 β 2020Richmond Heights, Missouri, United States
- Horizon DiscoveryChief Business Officer and Board Member2014 β 2015
- SAGE LabsChief Executive Officer2013 β 2014Greater St. Louis
- Sigma AldrichChief Scientific Officer2011 β 2012
- Sigma AldrichPresident2007 β 2011
- Sigma AldrichVice president2004 β 2007
- EMD BiosciencesVice President of Corporate Development2004Greater St. Louis
- ProteoplexCEO2002 β 2004St Louis
- Merck Milliporecorp dev VP2002 β 2004
- Incyte Genomicssr. vp of marketing2000 β 2002
- IncyteVp1996 β 2002
- Incyte Pharmaceuticalssr vp1996 β 2001
Skills & more
+12 more
ImmunologyTechnology TransferBiopharmaceuticalsProteomicsDrug DevelopmentCellProtein ChemistryBusiness StrategyAutomotivePharmaceutical IndustryR&DCommercializationFrom David's professional profile.
Deals Β· 2
Panome BioBoard seat
via Cultivation Capital Β· filed Nov 2024 Β· $6M raise
Maximum Fidelity Surgical Simulations, Inc.Board seat
via Cultivation Capital Β· filed Sep 2024 Β· $2.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Cultivation Capital
Network5
Investors connected to David in public investor directories β a warm-intro map.
Frequently asked questions
- Who is David Smoller?
- David Smoller is a life sciences executive who was CEO of Sage Labs, a gene-editing-based contract research organization acquired by Horizon Discovery, where he then served as Chief Business Officer and board member until December 2015. He previously held roles at Sigma-Aldrich Corporation, including Chief Scientific Officer and President of its Research Biotech Business Unit, and founded ProteoPlex (acquired by Merck KGaA) and Genome Systems Inc. (acquired by Incyte Corporation, where he later became Senior Vice President). He holds a doctorate in Molecular Biology and a bachelor's degree in Biology from Emory University.
- Where does David Smoller work?
- David Smoller is General Partner at Cultivation Capital and Board director at Panome Bio and Board director at Solis Agrosciences and Board director at Canopy Biosciences.
- What does David Smoller invest in?
- David Smoller invests in Biotech.
- What check size does David Smoller write?
- David Smoller typically writes checks of $100K β $3.5M.
- What boards does David Smoller sit on?
- David Smoller holds tracked board seats at Maximum Fidelity Surgical Simulations, Inc., Panome Bio, Solis Agrosciences.
- Where did David Smoller go to school?
- David Smoller studied at Ranken Technical College (Auto Technology, Auto Technology); Washington University in St. Louis (Postdoc, Genome Sciences/Genomics); Emory University (Doctor of Philosophy - PhD, biology).
Founder mafias
Washington University in St. Louis mafia42
Also came through, then founded or led a company.
+ 35 more
Emory University mafia28
Also came through, then founded or led a company.
+ 21 more
Cultivation Capital mafia8
Also came through, then founded or led a company.
+ 1 more
BioGenerator Ventures mafia2
Also came through, then founded or led a company.
Solis Agrosciences mafia2
Also came through, then founded or led a company.
Same school
Also attended Washington University in St. Louis173
+ 167 more
Also attended Emory University124
+ 118 more
